http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103566184-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8969 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 |
filingDate | 2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103566184-B |
titleOfInvention | A kind of Chinese medicine composition for the treatment of vascular endothelial inflammation injury and preparation method thereof |
abstract | The invention discloses a kind of Chinese medicine composition for the treatment of vascular endothelial inflammation injury, it comprises the component of following parts by weight: Rhizoma Polygonati (processed) 10 ~ 20 parts, Fructus Lycii 10 ~ 15 parts, Radix Rehmanniae 10 ~ 15 parts, Radix Rhodiolae 10 ~ 20 parts, Radix Notoginseng powder 5 ~ 10 parts, Rhizoma Chuanxiong 10 ~ 15 parts, dry Pheretima 10 ~ 15 parts, Radix Puerariae 10 ~ 20 parts, 10 ~ 20 parts, Folium Nelumbinis.The invention also discloses preparation method and the application of above-mentioned Chinese medicine composition.The clinical observation of Chinese medicine composition of the present invention shows it to effects such as insulin resistant, the reduction vascular inflammation factor, anticoagulant and certain blood sugar lowering, blood fat reducing, blood pressure lowerings.And pharmacological evaluation confirms that it has good inhibitory action and Efficacy of Protecting Vascular Endothelial to inflammatory factor. |
priorityDate | 2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 324.